Autonomix Medical, Inc. Common Stock
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresse… Read more
Autonomix Medical, Inc. Common Stock (AMIX) - Total Liabilities
Latest total liabilities as of December 2025: $1.65 Million USD
Based on the latest financial reports, Autonomix Medical, Inc. Common Stock (AMIX) has total liabilities worth $1.65 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Autonomix Medical, Inc. Common Stock - Total Liabilities Trend (2022–2025)
This chart illustrates how Autonomix Medical, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Autonomix Medical, Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of Autonomix Medical, Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Grace Breeding Ltd
TA:GRAC
|
Israel | ILA842.00K |
|
Dongil Technology Ltd
KQ:032960
|
Korea | ₩3.59 Billion |
|
Przedsiebiorstwo Przemyslu Spozywczego PEPEES S.A.
WAR:PPS
|
Poland | zł153.53 Million |
|
Aelis Farma SA
PA:AELIS
|
France | €9.46 Million |
|
Golden Pursuit Resources Ltd
PINK:FPVTF
|
USA | $863.44K |
|
Copper Strike Ltd
AU:CSE
|
Australia | AU$109.14K |
Liability Composition Analysis (2022–2025)
This chart breaks down Autonomix Medical, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.18 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.19 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.16 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Autonomix Medical, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Autonomix Medical, Inc. Common Stock (2022–2025)
The table below shows the annual total liabilities of Autonomix Medical, Inc. Common Stock from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | $1.71 Million | -4.05% |
| 2024-03-31 | $1.78 Million | +704.98% |
| 2023-03-31 | $221.00K | +137.02% |
| 2022-03-31 | $93.24K | -- |